Robert Hershberg

NanoString Technologies announced that Robert Hershberg has joined its board of directors as of March 2, bringing the total number of members to six.

Hershberg in July 2014 became VP of immuno-oncology at Celgene Corporation. He leads Celgene's early R&D efforts in that space and is in charge of the new Celgene Immuno-Oncology Center of Excellence in Seattle, Washington. Hershberg also founded and is CEO of VentiRx Pharmaceuticals and is an independent member of the board of directors for Adaptive Biotechnologies Corporation.